Rationale of azithromycin prescribing practices for enteric fever in India
1Department of Microbiology, UCMS and GTB Hospital, Dilshad Garden, Delhi - 110 095, India. sumit_rai@yahoo.com
Purpose:
The present study was performed to assess the current susceptibility pattern of blood isolates of Salmonella spp from a super specialty hospital in North India against nalidixic acid, ciprofloxacin and azithromycin and compare the in vitro and in vivo response against azithromycin.
Materials And Methods:
We evaluated the minimum inhibitory concentration's (MIC's) of 107 blood isolates of Salmonella spp against nalidixic acid, azithromycin and ciprofloxacin and correlated in vitro and in vivo response of azithromycin from the treatment and discharge summaries from the Hospital Information System (HIS) software.
Results:
Among the 107 isolates evaluated, 94 (87.8%) were nalidixic acid-resistant (NAR) Salmonella and 36 were resistant to azithromycin by MIC testing. The MIC 90 value for azithromycin was 24 μg/mL. Among the 57 treatment histories evaluated using the HIS software, 19 (33%) patients had documented clinical non-response to azithromycin which required change of therapy.
Conclusions:
The present study observed a higher MIC 90 values for azithromycin compared to Salmonella isolates from Western studies. There was also a documented clinical non-response against azithromycin. The in vitro and in vivo findings in this study suggest a guarded use of azithromycin for cases of enteric fever in India. The study also augments the reversal of resistance pattern in favour of chloramphenicol, ampicillin and trimethoprim - sulfamethoxazole.
Insights
Salmonella resistance to nalidixic acid is high in North India. Azithromycin shows reduced effectiveness in vitro and in vivo, suggesting cautious use for enteric fever.
Area of Science:
- Clinical Microbiology
- Infectious Diseases
- Antimicrobial Resistance
Background:
- Enteric fever, primarily caused by Salmonella spp., remains a significant public health concern in India.
- Emerging antimicrobial resistance poses a challenge to effective treatment strategies for Salmonella infections.
Purpose of the Study:
- To determine the current susceptibility patterns of Salmonella spp. blood isolates in North India against nalidixic acid, ciprofloxacin, and azithromycin.
- To compare the in vitro and in vivo efficacy of azithromycin in treating Salmonella infections.
Main Methods:
- Minimum Inhibitory Concentration (MIC) testing was performed on 107 blood isolates of Salmonella spp.
- In vitro susceptibility to nalidixic acid, ciprofloxacin, and azithromycin was evaluated.
- Correlation of in vitro findings with in vivo azithromycin response using treatment and discharge summaries from Hospital Information System (HIS) software.
Main Results:
- A high prevalence of nalidixic acid-resistant (NAR) Salmonella was observed (94%, 87.8%).
- 36% of isolates exhibited resistance to azithromycin, with an MIC 90 value of 24 μg/mL.
- Clinical non-response to azithromycin was documented in 33% of patients, necessitating a change in therapy.
Conclusions:
- The study indicates higher azithromycin MIC 90 values in Indian Salmonella isolates compared to Western studies.
- Documented clinical non-response highlights potential limitations of azithromycin for enteric fever in this region.
- A guarded approach to azithromycin use for enteric fever in India is recommended, with a potential resurgence of older antibiotics like chloramphenicol, ampicillin, and trimethoprim-sulfamethoxazole.
More Related Videos
Related Concept Videos
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Inhibitors of Bacterial DNA Synthesis
Endocarditis III: Medical Management
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Acute Pharyngitis
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:


